Novartis & Microsoft Collaborate On AI, Amazon Offers Health Services - ICT&health

Novartis announced the next step in reimagining medicine by founding the Novartis AI innovation lab and by selecting Microsoft Corp. as its strategic AI and data-science partner for this effort. The new lab aims to significantly bolster Novartis AI capabilities from research through commercialisation and help accelerate the discovery and development of transformative medicines for patients worldwide. As part of the strategic collaboration announced, Novartis and Microsoft have committed to a multi-year research and development effort. Microsoft and Novartis will also collaborate to develop and apply next-generation AI platforms and processes that support future programs across these two focus areas. The overall investment will include project funding, subject-matter experts, technology, and tools.